Researchers launch major study to unravel mysteries of rare lung infections

NCT ID NCT00018044

Recruiting now Knowledge-focused Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 33 times

Summary

This study aims to learn more about non-tuberculous mycobacterial (NTM) infections by observing up to 1,000 people over time. Researchers will collect medical history, blood samples, and genetic data to understand why some people get these infections and how the disease progresses. Participants will undergo tests like lung function exams, heart scans, and spine X-rays, but no new treatments are being tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JOB SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

Conditions

The condition(s) this trial relates to.

cystic fibrosis hyper-IgE recurrent infection syndrome 1, autosomal dominant mycobacterial infectious disease Mycobacterium avium complex disease Mycobacterium Infections, Nontuberculous pulmonary non-tuberculous mycobacterial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYCOBACTERIUM INFECTIONS